Who to call at Prothena Corporation, and when
Fundz watches for the moments Prothena Corporation starts buying, and tells you who to reach.
- An alert the day Prothena Corporation raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Prothena Corporation, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Prothena Corporation. With Fundz connected, it knows.
Contract Type
partnership
DublinBiotechnologyHealth CareTherapeuticsDescription
Prothena Corporation has initiated a partnership with Roche to develop prasinezumab, a treatment for Parkinson's disease. This collaboration allows Prothena to leverage Roche's clinical development expertise while mitigating the financial burden of advancing the treatment independently.
Quick answer
Prothena Partners with Roche to Advance Prasinezumab for Parkinson's Disease Treatment. (October 20, 2026). Prothena Corporation is based in Dublin, Dublin, Ireland.
- What agreement did Prothena Corporation announce on October 20, 2026?
- Prothena Corporation has initiated a partnership with Roche to develop prasinezumab, a treatment for Parkinson's disease. This collaboration allows Prothena to leverage Roche's clinical development expertise while mitigating the financial burden of advancing the treatment independently.
- What does Prothena Corporation do?
- Prothena Corporation plc is a late-stage clinical biotechnology company with a robust pipeline of investigational therapeutics built on protein dysregulation expertise.
- Where is Prothena Corporation based?
- Prothena Corporation is based in Dublin, Dublin, Ireland.
- Which similar companies announced agreements around the same time?
- YD Bio Limited (October 20, 2026), RxMP Therapeutics (October 20, 2026), Nuclidium (October 19, 2026) and Genmab A/S (October 24, 2026) also announced agreements within 45 days of Prothena Corporation.
Source: Fundz verified event record.
Other recent agreements in Therapeutics and Biotechnology
Contracts and agreements at companies in the same sectors within 45 days, from Fundz verified event records.
- YD Bio and EG BioMed Form Partnership with JoiiUp to Launch AI Cancer Risk Assessment for Corporate Wellness. (October 20, 2026)
- DARPA Awards Up to $10.7 Million Contract to RxMP Therapeutics for Development of RMP-402. (October 20, 2026)
- NUCLIDIUM and NorthStar Forge Long-term Strategic Partnership to Enhance Copper-67 Radiotheranostic Oncology Pipeline. (October 19, 2026)
- Genmab and Incyte collaborate on a colorectal cancer trial using petosemtamab and a mutation-targeting drug. (October 24, 2026)
- Menarini and Georgiamune Enter $1.1 Billion License Agreement for Cancer Immunotherapy GIM-621. (October 25, 2026)
- GondolaBio and Children’s Tumor Foundation Partner to Enhance Neurofibromatosis Type 1 Program Development. (October 26, 2026)
Related People
Agreement Insights
What this usually meansProthena Corporation signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.